Docebo (DCBO) Q3 2024 earnings summary

Executive summary

• Achieved $214M in Annual Recurring Revenue (ARR) as of September 30, 2024, with a 42% subscription revenue CAGR from 2020 to 2023 and strong Q3 performance driven by AI-powered innovation, new product launches, and expansion in enterprise and government sectors.

• Customer base grew to 3,945 globally, with 95% of Q3 2024 revenue from subscriptions and 81% of 2023 ARR from multi-year contracts; notable wins in cybersecurity, insurance, enterprise software, retail, and event management.

• Strategic focus on international expansion, especially in the DACH region, and leveraging partnerships with system integrators like Accenture, Deloitte, Google Cloud, and AWS.

• Leadership changes include a new CEO and key executive hires to strengthen go-to-market and product strategies.

• Focused on enterprise, government, and customer experience (CX) learning markets, leveraging AI and platform innovation.

Financial highlights

• Q3 2024 total revenue reached $55.4M, up 19% year-over-year; subscription revenue was $52.6M, up 21% and 95% of total.

• Adjusted EBITDA margin improved to 15.7% in Q3 2024 from 9.7% in Q3 2023; Adjusted EBITDA was $8.7M.

• Net income was $5.0M ($0.16/share), up from $4.0M ($0.12/share) in Q3 2023; Adjusted Net Income was $8.3M ($0.27/share).

• Free Cash Flow was $4.5M (8.2% of revenue), down from $8.4M (18.0%) due to bonus payouts and vendor payment timing; cumulative free cash flow of ~$30M since 2016.

• Cash and cash equivalents stood at $82.0M, up 14% from year-end 2023.

Outlook and guidance

• Q4 2024 revenue expected between $56.0M and $56.2M; Adjusted EBITDA margin between 16.5% and 16.7%.

• FY 2024 revenue growth guidance raised to ~19.5%; Adjusted EBITDA margin expected at ~15.5%.

• Pipeline for 2025 is increasingly weighted toward large enterprise and CX use cases, with over 50% of pipeline CX-driven.

• Targeting continued ARR and free cash flow growth, with a long-term goal to maintain a "Rule of 40" balance between growth and profitability.

• Expect continued deal cycle elongation in enterprise, but anticipate growth stability and potential ACV increases as pricing changes roll through renewals.